Langerhans Cell Histiocytosis (LCH) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E Mutation
Conditions: Langerhans Cell Histiocytosis; Erdheim-Chester Disease; LCH; ECD Intervention: Drug: HLX208 Sponsor: Shanghai Henlius Biotech Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2021 Category: Research Source Type: clinical trials
Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
Conditions: Histiocytosis; Histiocytosis, Langerhans-Cell; Histiocytosis Pulmonary Intervention: Other: Standard of care Sponsor: Assistance Publique - Hôpitaux de Paris Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2020 Category: Research Source Type: clinical trials
